Moreover, VDR being a direct activator of trpv6 promoter [17], and 1,25-dihydroxyvitamin D3 a widely used anticancer treatment have completed an intriguing hypothesis for TRPV6 regulation and significance in prostate cancer. This evidence concerns the gene TRPV6 and prostate carcinoma.